Larvol Delta - A-Study-to-Investigate-Pharmacokinetics-Pharmacodynamics-and-Safety-of-Subcutaneous-Anifrolumab-in-Pediatric-Participants-5-to-lt-18-Years-of-Age-With-Systemic-Lupus-Erythematosus

Saphnelo (anifrolumab-fnia) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT07630714

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next